Interpace enters $8M term loan with BroadOak at 9% to repay private equity loans

INTERPACE BIOSCIENCES, INC.

$8M term loan from BroadOak at 9% interest, matures Oct 2024 or change-of-control.
Proceeds used to repay $4.5M Ampersand and $3M 1315 Capital promissory notes plus interest.
Loan includes 3% origination fee and terminal payment of 15%-30% of original principal.
Subordinate to Comerica's $7.5M revolving facility; secured by substantially all assets.
Company believes new debt improves liquidity and operating flexibility without dilution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.